Literature DB >> 32624357

Advances in the diagnosis of pulmonary tuberculosis in children.

Mark P Nicol1, Heather J Zar2.   

Abstract

Major challenges still exist in the accurate diagnosis of tuberculosis in children. Algorithms based on clinical and radiological features remain in widespread use despite poor performance. Newer molecular diagnostics allow for rapid identification of TB and detection of drug-resistance in a subset of children, but lack sensitivity. Molecular testing of multiple specimens, including non-traditional specimen types, such as nasopharyngeal aspirates and stool and urine, may improve sensitivity, but the optimal combination of specimens requires further research. Novel tests under development or evaluation include a urine lipoarabinomannan test with improved sensitivity and a range of biomarkers measured from stimulated or unstimulated peripheral blood.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; Children; Diagnosis; LAM; Tuberculosis; Xpert

Year:  2020        PMID: 32624357     DOI: 10.1016/j.prrv.2020.05.003

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  2 in total

1.  Performance of Xpert MTB/RIF and Mycobacterial Culture on Multiple Specimen Types for Diagnosis of Tuberculosis Disease in Young Children and Clinical Characterization According to Standardized Research Case Definitions.

Authors:  Eleanor S Click; Rinn Song; Jonathan P Smith; Walter Mchembere; Mark Fajans; Parisa Hariri; Elisha Okeyo; Kimberly D McCarthy; Dickson Gethi; Lazarus Odeny; Susan Musau; Albert Okumu; James Orwa; Carlos M Perez-Velez; Colleen A Wright; Mariaem Andres; Ben J Marais; H Simon Schaaf; Stephen M Graham; Andrea T Cruz; Kevin P Cain
Journal:  Pediatr Infect Dis J       Date:  2022-07-13       Impact factor: 3.806

2.  Pediatric Tuberculosis Disease during Years of High Refugee Arrivals: A 6-Year National Prospective Surveillance Study.

Authors:  Nora Fritschi; Axel J Schmidt; Jürg Hammer; Nicole Ritz
Journal:  Respiration       Date:  2021-07-29       Impact factor: 3.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.